Movement Alert｜Hims & Hers Health Inc. Rises 5.53% in Regular Trading, Needham Raises Target Price to $42 Triggering Technical Rebound

Market Focus08-28 03:10

On August 28, Hims & Hers Health Inc. rose 5.53% in regular trading, trading at $31.63/share, with turnover of $194 million.

On the news front, Needham raised its price target on the company to $42, while Truist Securities also recently lifted its target from $27 to $32 maintaining a Hold rating. Multiple analyst upgrades boosted market sentiment after consecutive sessions of selling pressure.

The stock had previously declined approximately 8% on August 24 and 5% on August 26 after Visa placed the company on its Acquirer Monitoring Program due to a surge in credit card disputes in its weight-loss subscription business, and Barclays cut its target price from $39 to $35 while maintaining an Overweight rating. Following these back-to-back declines, technical rebound momentum accumulated, with the bullish analyst actions providing a catalyst for recovery.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1150179492?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-28 03:10","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1150179492","market":"us","top_or_hot":-1,"title":"Movement Alert｜Hims & Hers Health Inc. Rises 5.53% in Regular Trading, Needham Raises Target Price to $42 Triggering Technical Rebound","media":"Market Focus","content":"<p><p>On August 28, Hims & Hers Health Inc. rose 5.53% in regular trading, trading at $31.63/share, with turnover of $194 million.</p><p>On the news front, Needham raised its price target on the company to $42, while Truist Securities also recently lifted its target from $27 to $32 maintaining a Hold rating. Multiple analyst upgrades boosted market sentiment after consecutive sessions of selling pressure.</p><p>The stock had previously declined approximately 8% on August 24 and 5% on August 26 after Visa placed the company on its Acquirer Monitoring Program due to a surge in credit card disputes in its weight-loss subscription business, and Barclays cut its target price from $39 to $35 while maintaining an Overweight rating. Following these back-to-back declines, technical rebound momentum accumulated, with the bullish analyst actions providing a catalyst for recovery.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜Hims & Hers Health Inc. Rises 5.53% in Regular Trading, Needham Raises Target Price to $42 Triggering Technical Rebound</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜Hims & Hers Health Inc. Rises 5.53% in Regular Trading, Needham Raises Target Price to $42 Triggering Technical Rebound\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-08-28 03:10</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On August 28, Hims & Hers Health Inc. rose 5.53% in regular trading, trading at $31.63/share, with turnover of $194 million.</p><p>On the news front, Needham raised its price target on the company to $42, while Truist Securities also recently lifted its target from $27 to $32 maintaining a Hold rating. Multiple analyst upgrades boosted market sentiment after consecutive sessions of selling pressure.</p><p>The stock had previously declined approximately 8% on August 24 and 5% on August 26 after Visa placed the company on its Acquirer Monitoring Program due to a surge in credit card disputes in its weight-loss subscription business, and Barclays cut its target price from $39 to $35 while maintaining an Overweight rating. Following these back-to-back declines, technical rebound momentum accumulated, with the bullish analyst actions providing a catalyst for recovery.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"HIMS","symbol_name":"Hims & Hers Health Inc.","start_time":0,"source_url":"","article_id":"1150179492","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1150179492","pubTimestamp":1787857805,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On August 28, Hims & Hers Health Inc. rose 5.53% in regular trading, trading at $31.63/share, with turnover of $194 million.On the news front, Needham raised its price target on the company to $42,...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"HIMS":"Hims & Hers Health Inc."},"translate_title":"走势警报|Hims & Hers Health Inc. 常规交易中上涨 5.53%，Needham 将目标价上调至 42 美元，引发技术性反弹","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"HIMS":1},"content_text":"On August 28, Hims & Hers Health Inc. rose 5.53% in regular trading, trading at $31.63/share, with turnover of $194 million.On the news front, Needham raised its price target on the company to $42, while Truist Securities also recently lifted its target from $27 to $32 maintaining a Hold rating. Multiple analyst upgrades boosted market sentiment after consecutive sessions of selling pressure.The stock had previously declined approximately 8% on August 24 and 5% on August 26 after Visa placed the company on its Acquirer Monitoring Program due to a surge in credit card disputes in its weight-loss subscription business, and Barclays cut its target price from $39 to $35 while maintaining an Overweight rating. Following these back-to-back declines, technical rebound momentum accumulated, with the bullish analyst actions providing a catalyst for recovery.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.48.0","shortVersion":"4.48.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1150179492","isCrawlerRequest":true}